Your browser doesn't support javascript.
loading
Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency.
Yang, Linlin; Booth, Claire; Speckmann, Carsten; Seidel, Markus G; Worth, Austen J J; Kindle, Gerhard; Lankester, Arjan C; Grimbacher, Bodo; Gennery, Andrew R; Seppanen, Mikko R J; Morris, Emma C; Burns, Siobhan O.
Afiliação
  • Yang L; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom; Institute for Immunity and Transplantation, University College London, London, United Kingdom; Department of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen Uni
  • Booth C; Department of Immunology and Gene Therapy, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom; Molecular and Cellular Immunology, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Speckmann C; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany; Center for Pediatrics and Adolescent Medicine, Department of Pediatric Hematology and Oncology, Faculty of Medicine, Medical Center-University of
  • Seidel MG; Research Unit for Pediatric Hematology and Immunology, Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • Worth AJJ; Department of Immunology and Gene Therapy, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom.
  • Kindle G; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
  • Lankester AC; Department of Pediatrics, Stem Cell Transplantation Program, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
  • Grimbacher B; Institute for Immunity and Transplantation, University College London, London, United Kingdom; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany; DZIF-German Center for Infection Research, Satellit
  • Gennery AR; Translational and Clinical Research Institute, Newcastle University and Pediatric Immunology + HSCT, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.
  • Seppanen MRJ; HUS Rare Disease Center, Children and Adolescents, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Morris EC; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom; Institute for Immunity and Transplantation, University College London, London, United Kingdom.
  • Burns SO; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom; Institute for Immunity and Transplantation, University College London, London, United Kingdom. Electronic address: siobhan.burns@ucl.ac.uk.
J Allergy Clin Immunol ; 150(2): 456-466, 2022 08.
Article em En | MEDLINE | ID: mdl-34920033
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Linfo-Histiocitose Hemofagocítica Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Linfo-Histiocitose Hemofagocítica Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2022 Tipo de documento: Article